Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
Kwong WJ, Ozer-Stillman I, Miller JD, Haber NA, Russell MW, Kavanagh S. Kwong WJ, et al. Clin Ther. 2010 Sep;32(10):1768-81. doi: 10.1016/j.clinthera.2010.09.011. Clin Ther. 2010. PMID: 21194601
Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
Kwong WJ, Diels J, Kavanagh S. Kwong WJ, et al. Ann Pharmacother. 2010 Apr;44(4):630-40. doi: 10.1345/aph.1M520. Epub 2010 Mar 2. Ann Pharmacother. 2010. PMID: 20197473
Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.
von Schéele B, Fernandez M, Hogue SL, Kwong WJ. von Schéele B, et al. Among authors: kwong wj. Ann Pharmacother. 2013 May;47(5):671-85. doi: 10.1345/aph.1R411. Epub 2013 Apr 19. Ann Pharmacother. 2013. PMID: 23606551 Review.
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.
Preblick R, Kwong WJ, White RH, Goldhaber SZ. Preblick R, et al. Among authors: kwong wj. Hosp Pract (1995). 2015;43(5):249-57. doi: 10.1080/21548331.2015.1099412. Epub 2015 Nov 7. Hosp Pract (1995). 2015. PMID: 26549305
Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
Kwong WJ, Parasuraman TV. Kwong WJ, et al. Pharm Pract Manag Q. 1999 Apr;19(1):28-41. Pharm Pract Manag Q. 1999. PMID: 10351607
Economic implications of early treatment of migraine with sumatriptan tablets.
Cady RK, Sheftell F, Lipton RB, Kwong WJ, O'Quinn S. Cady RK, et al. Among authors: kwong wj. Clin Ther. 2001 Feb;23(2):284-91. doi: 10.1016/s0149-2918(01)80011-4. Clin Ther. 2001. PMID: 11293561
Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review.
Boswell K, Kwong WJ, Kavanagh S. Boswell K, et al. Among authors: kwong wj. J Opioid Manag. 2010 Jul-Aug;6(4):269-89. doi: 10.5055/jom.2010.0025. J Opioid Manag. 2010. PMID: 20862907 Review.
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.
AbuDagga A, Stephenson JJ, Fu AC, Kwong WJ, Tan H, Weintraub WS. AbuDagga A, et al. Among authors: kwong wj. BMC Health Serv Res. 2014 Jul 17;14:310. doi: 10.1186/1472-6963-14-310. BMC Health Serv Res. 2014. PMID: 25034699 Free PMC article.
The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ. Casciano JP, et al. Among authors: kwong wj. J Manag Care Pharm. 2013 May;19(4):302-16. doi: 10.18553/jmcp.2013.19.4.302. J Manag Care Pharm. 2013. PMID: 23627576
Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC. Casciano JP, et al. Among authors: kwong wj. Am J Cardiovasc Drugs. 2012 Oct 1;12(5):313-23. doi: 10.1007/BF03261840. Am J Cardiovasc Drugs. 2012. PMID: 22920047
55 results
Jump to page
Feedback